APHSS Announces September’s Scheduled Syphilis Program for Testing to Start Immediately
CANOGA PARK, Calif. – Adult Production Health & Safety Services (APHSS.org) has announced that the semi-annual syphilis testing program scheduled for September will instead begin immediately and run through the end of September.
The action follows recent unsubstantiated rumors of a syphilis incident among adult performers. Due to concerns raised by performers and producers, and with a desire to provide optimal care, APHSS.org made the decision to launch the program immediately, in order to alleviate any further concerns. The Center for Disease control, the National Institute of Health and the Department of Public Health recommend testing for syphilis only once a year and for highly sexually-active populations twice a year. Originally, the syphilis testing program was scheduled for the months of September and March.
“Though there has been no confirmation of these rumors, we have heard the concerns of producers and performers, and their well-being is our primary concern,” said FSC Executive Director Diane Duke. “By launching the program early, performers can go to APHSS-recommended testing facilities and get tested for syphilis for free, along with their regular performer tests panel.”
The testing facilities that will offer free syphilis testing through the end of September include Cutting Edge Testing, SameDayTest.com (AMTC), and STDStatus.com. Contact information for these facilities can be found at the APHSS.org website. https://aphss.org/performer-info
While there has been no confirmation of any syphilis infections in the U.S. performer population, APHSS policy dictates pro-active procedures to ensure that industry self-regulation protocols are observed. Any cases of syphilis tested within the system would follow those protocols, which includes partner identification.
Center for Disease Control guidelines for syphilis can be found at this link: http://www.cdc.gov/std/syphilis/stdfact-syphilis.htm.
Syphilis is treatable. Early detection of syphilis is the key to fast, effective treatment with antibiotics. Individuals that may have had syphilis previously and been treated should be aware that antibodies created by the infection may trigger a “false positive” result and, in those cases, confirmatory tests must be administered to confirm any possible active infection. Any extra tests may take additional days to complete.
If you have questions or need more information about syphilis testing or APHSS.org, please contact
Response to Statement by Talent Testing Services
CANOGA PARK, Calif. – The following is a statement issued by Adult Production Health & Safety Services (APHSS.org) in regards to a Talent Testing Services Press release sent to industry media outlets earlier today:
This is the first word we have received from Talent Testing Services that they have chosen to stop sending data to the APHSS database. We regret this decision by TTS since it will have a negative effect on performers and producers. Further, it obviously endangers adult production industry self-regulation protocols, especially at a time when the industry is under fire from outside interests that support mandatory condom legislation.
We have done everything possible to compromise with TTS – despite their objections to participation in APHSS – because we had requests from several producers and agents to include TTS data in the APHSS database. We agreed with producers and agents that including TTS data was the best possible situation for the industry (despite their unwillingness to comply with APHSS policy & protocols), in order to have a complete source of information for active performers.
If TTS is currently in dispute with Manwin over alleged demands placed on them for further cooperation, APHSS cannot comment on these developments as they do not directly involve any negotiations that we have had with TTS. APHSS responded to TTS’ initial demands by providing them with an automated interface to load data into the APHSS system. At that time, TTS agreed to follow APHSS protocols in the event of an STI exposure incident.
However, because of other objections from TTS to APHSS policy, they declined to be included in the APHSS program and so were not able to become an APHSS-recommended facility. It seems that now they have decided to drop out of the program completely, based on their own business interests.
We assume that Manwin has based their company policy on what is most prudent for them, and we commend them for giving serious consideration to establishing health & safety protocols for their company.
The APHSS database was developed by industry stakeholders, attorneys and compliance experts to be a comprehensive source of information, to safeguard self-regulation protocols – as well as providing performers with reliable health services that include doctors and healthcare professionals. The database design was also developed to safeguard user privacy and security.
APHSS-recommended facilities have been chosen from established healthcare providers that have agreed to abide by industry self-regulation protocols, including the presence of on-staff physicians and adherence to STI exposure protocols. Many of those protocols are based on those developed by the AIM clinic. These components are essential to any industry self-regulation – without them, the industry has little defense against mandated regulation by governmental entities. The essence of those protocols have been effective since they were established in 1998.
In addition, the recently-initiated Performer Subsidy Fund is to be administered through the APHSS system, which will subsidize testing for all performers whose testing data is updated through the APHSS system. Without voluntary TTS updates for performers that choose to use their services, we cannot hope to know which performers have tested there, so subsidizing their test fees will be nearly impossible. Most critically, it will also be impossible for APHSS to gather data on performers that test at TTS, in the event of an exposure incident.
Again, we have had little communication from TTS concerning these latest developments and we hope that their representatives will reconsider the potential repercussions that their decisions will have on the entire adult production community.
We encourage producers and performers to consider carefully their own policies toward industry testing and STI protocols, but acknowledge that all are free to choose the services they wish to use. Producers and performers wanted - and have a right - to a system that offers them choice, reliability and, most importantly, cooperation in the event of any STI exposure incident. APHSS will continue to provide those services and more, now and in the future.
APHSS Proudly Announces New Performer Testing Service
CANOGA PARK, Calif. – Adult Production Health & Safety Services (APHSS.org) is glad to announce a new addition to its network of performer testing facilities. STDStatus.com is currently offering performer-testing services at draw stations located nationwide.
“We are thrilled to be able to offer more options to performers for testing, especially performers that are located outside of the Los Angeles area,” said FSC Executive Director Diane Duke (FSC operates APHSS.org). “To comply with APHSS policy, STDStatus.com works with a national network of doctors and service providers, and they offer the Aptima HIV-1RNA Qualitative Assay test. It’s exciting to welcome them to the program.”
A unique feature of the STDStatus.com website is a “live chat” option where clients may ask general questions about testing and test locations via chat. STDStatus.com can also be reached by phone at 1-866-554-4296, 24 hours a day.
Performers and producers can expect STDStatus.com to return test results within 3-4 business days, with a cost of $149.00 for the performer’s panel of tests. In addition to the industry standard panel of tests, STDStatus.com also will include syphilis testing – free of charge – for performers.
“We are very excited to have partnered with APHSS in helping to maintain reliable health services for performers,” STDStatus.com President Michelle Leone said. “We look forward to extending our professional and convenient testing services to the adult entertainment industry.”
For more information on the APHSS.org program, please contact (818) 348-9373 or
Manwin Initiates Fund to Subsidize Performer Testing Costs Through FSC-APHSS.org
CANOGA PARK, Calif. – Free Speech Coalition (FSC) has been called upon by Manwin to administer a fund through which performers may receive a monthly subsidy to help with costs of industry-imposed STI testing.
Called the Performer Subsidy Fund, the program will be available to all active performers who participate in the Adult Production Health & Safety Services (APHSS.org) database, even if they do not perform in a Manwin production.
The action follows a recent policy change for Manwin, requiring performers that work on productions for Manwin brands to increase STI testing to every 14 days, instead of the industry standard 28-day testing. Any performer that tests, and is a participant in the APHSS database program can receive a subsidy, even if they test only every 28 days, and do not shoot for any Manwin owned brands.
Manwin Managing Partner, Fabian Thylmann says: “This Fund was conceptualized to alleviate some of the expenses, and financial burden, performers may be facing due to occupational testing. We’re grateful the FSC agreed to support this project, and hope others in the industry will back it as well.”
Manwin has agreed to contribute $50,000 monthly to the Performers Subsidy Fund. Other adult production companies, and producers, also are invited to contribute to the cause.
Manwin is providing a separate amount to the FSC, to cover all administration costs of the program.
Performers that are currently participating in the APHSS.org database system will be asked to submit a mailing address in advance of the first round of funding subsidies. The first dispersal of funds is scheduled to take place in early September; performers that wish to receive the September subsidy must be signed up with APHSS.org by August 31.
Performers testing history will be tracked through the APHSS.org database, in order to compile needed information that will determine monthly subsidy dispersal. All funds will be divided equally among performers and performers will be subsidized per test for each test that they have taken in a given month.
Subsidy amounts will vary from month to month according to the number of tests identified in the APHSS database for a given month. Test subsidies will not exceed the average price of an industry-standard performer’s test panel ($120). If there are any surplus funds left after performers receive monthly subsidies, the excess will be put into a separate account that will be reserved for use in the event of an on-set HIV exposure incident. One hundred percent of the funds contributed to the subsidy will be designated to the performers and/or the emergency fund.
“When Manwin called and told me that they wanted to help all performers by subsidizing the cost of test, we were thrilled. They put up the funds and we will implement the program. The program is open for other producers to contribute as well — the more money that comes in, the more we will be able to send to performers,” said FSC Executive Director Diane Duke.
For more information on Free Speech Coalition, APHSS.org or the Performers Subsidy Fund, please contact